✦ LIBER ✦

Risk stratification and patient counseling for natalizumab in multiple sclerosis

✍ Scribed by Fox, R. J.; Rudick, R. A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multiple sclerosis: Risk factors for pro

✍ Kumar Shetty, Pradeep; Rodrigues, L. Lewlyn. R. 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB

Natalizumab treatment for multiple scler

✍ Ludwig Kappos; David Bates; Hans-Peter Hartung; Eva Havrdova; David Miller; Chri 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 249 KB

Natalizumab treatment for multiple scler

✍ Ludwig Kappos; David Bates; Gilles Edan; Mefkûre Eraksoy; Antonio Garcia-Merino; 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 414 KB

Empiric recurrence risks for use in the

✍ Sadovnick, A. D. ;Opitz, John M. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Carnitine serum levels and levocarnitine

✍ M. Laffon-Pioger; F. Rocher; C. Caruba; M. Cohen; P. Thomas; C. Lebrun 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PND35 IMPACT OF NATALIZUMAB ON PATIENT O

✍ JJ Stephenson; K Rajagopalan; S Kamat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB